Export 8 results:
Author Title [ Type(Desc)] Year
Filters: Author is Ling, Walter  [Clear All Filters]
Journal Article
W. Ling, Hillhouse, M. P., Saxon, A. J., Mooney, L. J., Thomas, C. M., Ang, A., Matthews, A. G., Hasson, A., Annon, J., Sparenborg, S., Liu, D. S., McCormack, J., Church, S., Swafford, W., Drexler, K., Schuman, C., Ross, S., Wiest, K., P Korthuis, T., Lawson, W., Brigham, G. S., Knox, P. C., Dawes, M., and Rotrosen, J., Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study., Addiction, vol. 111, no. 8, pp. 1416-27, 2016.
Y. Mao, Wu, Z., McGoogan, J. M., Liu, D., Gu, D., Erinoff, L., Ling, W., VanVeldhuisen, P., Detels, R., Hasson, A. L., Lindblad, R., Montaner, J. S. G., Tang, Z., and Zhao, Y., Care cascade structural intervention versus standard of care in the diagnosis and treatment of HIV in China: a cluster-randomized controlled trial protocol., BMC Health Serv Res, vol. 17, no. 1, p. 397, 2017.
L. J. Mooney, Nielsen, S., Saxon, A., Hillhouse, M., Thomas, C., Hasson, A., Stablein, D., McCormack, J., Lindblad, R., and Ling, W., Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology., Contemp Clin Trials, vol. 34, no. 2, pp. 196-204, 2013.
Y. - I. Hser, Evans, E., Huang, D., Weiss, R., Saxon, A., Carroll, K. M., Woody, G., Liu, D., Wakim, P., Matthews, A. G., Hatch-Maillette, M., Jelstrom, E., Wiest, K., McLaughlin, P., and Ling, W., Long-term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi-site trial., Addiction, vol. 111, no. 4, pp. 695-705, 2016.
D. Gu, Mao, Y., Tang, Z., Montaner, J., Shen, Z., Zhu, Q., Detels, R., Jin, X., Xiong, R., Xu, J., Ling, W., Erinoff, L., Lindblad, R., Liu, D., Van Veldhuisen, P., Hasson, A., and Wu, Z., Loss to Follow-Up from HIV Screening to ART Initiation in Rural China., PLoS One, vol. 11, no. 10, p. e0164346, 2016.
J. D. Lee, Nunes, E. V., Mpa, P. Novo, Bailey, G. L., Brigham, G. S., Cohen, A. J., Fishman, M., Ling, W., Lindblad, R., Shmueli-Blumberg, D., Stablein, D., May, J., Salazar, D., Liu, D., and Rotrosen, J., NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale., Contemp Clin Trials, vol. 50, pp. 253-64, 2016.
Z. Wu, Tang, Z., Mao, Y., Van Veldhuisen, P., Ling, W., Liu, D., Shen, Z., Detels, R., Lan, G., Erinoff, L., Lindblad, R., Gu, D., Tang, H., Hu, L., Zhu, Q., Lu, L., Oden, N., Hasson, A. L., Zhao, Y., McGoogan, J. M., Ge, X., Zhang, N., Rou, K., Zhu, J., Wei, H., Shi, C. X., Jin, X., Li, J., and Montaner, J. S. G., Testing and linkage to HIV care in China: a cluster-randomised trial., Lancet HIV, vol. 4, no. 12, pp. e555-e565, 2017.
L. J. Mooney, Hillhouse, M. P., Thomas, C., Ang, A., Sharma, G., Terry, G., Chang, L., Walker, R., Trivedi, M., Croteau, D., Sparenborg, S., and Ling, W., Utilizing a Two-stage Design to Investigate the Safety and Potential Efficacy of Monthly Naltrexone Plus Once-daily Bupropion as a Treatment for Methamphetamine Use Disorder., J Addict Med, vol. 10, no. 4, pp. 236-43, 2016.